| Name | p-Ethynylphenylalanine hydrochloride |
| Description | p-Ethynylphenylalanine hydrochloride (4-Ethynyl-L-phenylalanine HCL) is a novel, potent, and specific inhibitor of TPH[1]. Its potential to selectively and reversibly inhibit serotonin biosynthesis may contribute to characterizing the role of serotonin in behavioral and physiological activities[1]. |
| In vitro | p-Ethynylphenylalanine hydrochloride was demonstrated to inhibit competitively and reversibly TPH in vitro (Ki = 32.6 +/- 6.2 microM vs. tryptophan)[1]. |
| In vivo | Administration of p-Ethynylphenylalanine hydrochloride (30 mg/kg) to rats produced a 95 +/- 5% decrease in TPH activity in brain homogenates and a concomitant decrease in serotonin and 5-hydroxyindole-3-acetic acid levels (85%) at 24 h after injection[1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | H2O : 12 mg/mL (53.17 mM), Sonication is recommended.
DMSO : 99 mg/mL (438.69 mM), Sonication is recommended.
|
| Keywords | Tryptophan Hydroxylase | Tryptophan hydroxylase | tryptophan | TPH | serotonin | p-Ethynylphenylalanine Hydrochloride | pEthynylphenylalanine hydrochloride | p-Ethynylphenylalanine | p Ethynylphenylalanine hydrochloride | Inhibitor | inhibit | hydroxylase | 5-HT | 5-HIAA |
| Inhibitors Related | p-Ethynylphenylalanine | Mildronate | Tetrahydropapaverine hydrochloride | Casein | p-Fluoro-L-phenylalanine | Telotristat Etiprate | Ketoconazole | Bupicomide | Ro 61-8048 | Diethyl-pythiDC | Fenclonine | Nepicastat hydrochloride |
| Related Compound Libraries | Bioactive Compound Library | Inhibitor Library | NO PAINS Compound Library | Metabolism Compound Library | Bioactive Compounds Library Max | Covalent Inhibitor Library |
United States
